Rhumbline Advisers Inotiv, Inc. Transaction History

Rhumbline Advisers

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$3.01 - $7.32 $1,812 - $4,406	-602 Reduced 44.69%	745 $2,000
Q2 2023 Aug 08, 2023	SELL	$4.08 - $7.22 $137,577 - $243,458	-33,720 Reduced 96.16%	1,347 $6,000
Q1 2023 May 11, 2023	BUY	$4.18 - $8.64 $36,236 - $74,900	8,669 Added 32.84%	35,067 $152,000
Q4 2022 Feb 14, 2023	BUY	$3.77 - $22.1 $124 - $729	33 Added 0.13%	26,398 $130,000
Q3 2022 Nov 10, 2022	BUY	$9.81 - $26.17 $15,333 - $40,903	1,563 Added 6.3%	26,365 $444,000
Q2 2022 Aug 11, 2022	BUY	$9.56 - $25.91 $80,256 - $217,514	8,395 Added 51.17%	24,802 $238,000
Q1 2022 May 12, 2022	BUY	$18.52 - $40.41 $78,080 - $170,368	4,216 Added 34.58%	16,407 $430,000
Q4 2021 Feb 10, 2022	BUY	$30.55 - $57.88 $103,595 - $196,271	3,391 Added 38.53%	12,191 $513,000
Q3 2021 Nov 12, 2021	BUY	$23.69 - $49.93 $208,472 - $439,384	8,800 New	8,800 $257,000

3.67M

1.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $68.6M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.